Pharma/Device Enforcement: A Year In Review

Law360, New York (February 11, 2011, 2:41 PM EST) -- For pharmaceutical and medical device companies, 2010 was a year marked by new enforcement developments and the deepening of several ongoing trends. Enforcement actions by the U.S. Department of Justice, the U.S. Food and Drug Administration, and the U.S. Department of Health and Human Services Office of Inspector General (OIG) continued to unfold with dizzying frequency and at considerable cost to the industry.

Although no single settlement matched the record $2.3 billion settlement from 2009, the 23 federal settlements against drug and device makers in 2010...
To view the full article, register now.